Adam Machaj is a retired boxer and ceased to hold a licence from the British Boxing Board of Control (BBBoC) from November 2018. Since 2015 he underwent medical treatment for his diagnosed low libido problem. Initially he had used prescribed Clomifene and Anastrozole but later used Testosterone by injection regularly which improved his Testosterone levels significantly.
In a Channel 4 TV Programme he participated and was broadcasted in Januay 2018, he was interviewed about tablets of Clomifene found in his possession. Hereafter the Athlete made three retrospective TUE applications for the use of the substances which were all rejected by the TUE Committee.
As a result in December 2019 the United Kingdom Anti-Doping (UKAD) has reported multipe anti-doping rule violations against the Athlete for the use the prohibited substances Clomifene, Anastrozole and Testosterone. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Panel.
The Athlete gave a prompt admission and denied the intentional use of these substances. He demonstrated with medical evidence that theses prescribed substances were used as treatment for his medical condition. The Athlete acknowledged that he previously had lied to the BBBoC medical practitioners about the use of Clomifene and Anastrozole because this was an embarrassing topic for him.
Considering the evidence the Panel agrees that the substances were used by the Athlete for medical reasons. However the Panel considers that undoubtedly the Athlete had concealed his use of Clomifene and Anastrozole in 2016 during the medical examination for the renewal of his BBBoC licence.
Furthermore the Panel deems that the Athlete took no steps at all to check the compatibility of these substances with professional boxing in circumstances he knew that there was at least a significant risk that they were prohibited and manifestly disregarded that risk. As a result he failed to establish that the violation was not intentional.
Therefore the National Anti-Doping Panel decides 4 September 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date the Athlete ceased to hold a professional licence, i.e. on 14 November 2018. All the Athlete’s results in contests since September 2015, when he started using Clomifene, are disqualified.
